news

Dec 20 2017
Ocugen Expands Focus on Inherited Retinal Disorders by Licensing Novel Modifier Gene Therapy Platform

Dec 5 2017
CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases

Nov 29 2017
Rebiotix Announces Expansion of Phase 1 Trial of the Company’s Oral Capsule Microbiota Product, RBX7455, Following Successful Completion of Initial Study Arms


 

events

Jan 8-11 2018
JP Morgan Healthcare Conference

Jan 8-10 2018
Biotech Showcase 2018

Jan 12-14 2018
The American Professional Society of ADHD and Related Disorders

Jan 29-30 2018
Noble Financial 14th Annual Equity Conference


 

spotlight